Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. - Wikidata - wikimedia - TriplyDB

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

http://www.wikidata.org/entity/Q36465265

about

Proliferating cell nuclear antigen in the cytoplasm interacts with components of glycolysis and cancer Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression miRNAs in breast cancer tumorigenesis (Review)Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress Anti-cancer effect of thiacremonone through down regulation of peroxiredoxin 6 Proteomic analyses of the Xiphophorus Gordon-Kosswig melanoma model.Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer.Neuroprotective effect of peroxiredoxin 6 against hypoxia-induced retinal ganglion cell damage.Screening and functional analysis of a differential protein profile of human breast cancer The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer's Disease.Fast proteomic protocol for biomarker fingerprinting in cancerous cells.Intact-protein analysis system for discovery of serum-based disease biomarkers.Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells Bioinformatics analysis of proteomic profiles during the process of anti-Thy1 nephritis NRF2, cancer and calorie restriction Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE Mitochondrial proteomics of nasopharyngeal carcinoma metastasis Elevated transcription of the gene QSOX1 encoding quiescin Q6 sulfhydryl oxidase 1 in breast cancer.Tuning of peroxiredoxin catalysis for various physiological roles Peroxiredoxin 6 interferes with TRAIL-induced death-inducing signaling complex formation by binding to death effector domain caspase.Stanniocalicin 2 suppresses breast cancer cell migration and invasion via the PKC/claudin-1-mediated signaling.Impact of genomic stability on protein expression in endometrioid endometrial cancer.Identification of potential breast cancer markers in nipple discharge by protein profile analysis using two-dimensional nano-liquid chromatography/nanoelectrospray ionization-mass spectrometry.Compensatory Islet Response to Insulin Resistance Revealed by Quantitative Proteomics.Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice.Discovery of biomarkers for osteosarcoma by proteomics approaches Allelic variants of glutathione S-transferase P1-1 differentially mediate the peroxidase function of peroxiredoxin VI and alter membrane lipid peroxidation.Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy Thymoquinone Alleviates the Experimental Diabetic Peripheral Neuropathy by Modulation of Inflammation.Tamoxifen resistance in breast cancer.Quantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population.Loss of NF-kappaB control and repression of Prdx6 gene transcription by reactive oxygen species-driven SMAD3-mediated transforming growth factor beta signaling Epigenetic regulation of peroxiredoxins: Implications in the pathogenesis of cancer.Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach.The role of peroxiredoxins in cancer.Molecular pathology of retinoblastoma.Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A₂ activities.Novel roles of peroxiredoxins in inflammation, cancer and innate immunity.Phospholipase A(2) of peroxiredoxin 6 has a critical role in tumor necrosis factor-induced apoptosis.

P2860

Q24300118-7104CA74-2905-4A79-AF06-406E38E75747 Q24568374-ACE7ABCF-4D48-4F4B-A514-32D02CE7508E Q26824561-05F8E3A6-8B78-430B-A602-455981DFCA9C Q28295105-0B8BF6FC-1CAA-403B-9F06-B02844072FFC Q28540752-CC761F85-0DEB-4524-AF31-10323FA4931D Q30423099-5DC412BB-981C-4609-9B8E-B80AADF9C1D0 Q33362180-DF73343F-2AD5-49F7-A0C0-2D19A3526FBC Q33711010-D48952EC-9D35-47BC-B84A-13C63183D3DF Q33727501-9E8730E5-D1E6-49BE-BE86-151CC8512154 Q33737263-5BE1AFE0-4D40-4945-B65B-EBA24B6A925F Q33798196-0AAB75D3-F7F8-44B4-BC47-96A07059E610 Q33863832-EE4CDCA1-52EA-424D-AACC-15336CF564AF Q34014666-979AF6D9-6728-4035-BB85-0DF03AC0E4FB Q34096857-3DE170E5-5F85-433D-AA69-522F819B7237 Q34148599-01EC3B75-8389-44C9-93EA-511AC2FE099F Q34202846-CACCF203-7111-412D-A8A9-3DEE3A8674BB Q34502955-A575E05A-92E1-4C7C-A5E0-B0D533A4EADE Q34608490-2A83C736-00BC-4A10-8846-868D0238E13F Q34731736-A1C1C270-059F-4844-848C-25749E894ED5 Q35092846-C611EE40-15B9-4BFE-8B61-3A4D09AF916E Q35242102-CDF6C3BC-062F-4CAA-A955-7808CD07BDB5 Q35859002-8C67D768-EFA3-47E2-BEF3-8595AA4A65DB Q35955117-C0F35773-3EF6-4089-B704-325507A3B115 Q36191447-B2D01064-DD0F-41CA-8546-8172909C1DF7 Q36373621-5E141414-6636-4E57-9846-1C2906B67C17 Q36440338-DE571EDE-9ED5-43FC-9A22-97988EE047A9 Q36515054-763694BB-ECA3-4D0A-9229-3306034157B8 Q36738790-DBA9C32D-DDAD-44C3-B256-216526811204 Q36877600-36BB7311-829F-48B5-A909-C938AFD792D1 Q37193185-109D229B-BC52-4BCA-8DF2-A952A9C9DCC7 Q37224555-CDDF0269-1F8C-44EB-A336-3EC4C3BEB394 Q37351381-2331D104-7589-458D-8A41-3B166A0C9B62 Q37371652-926E4231-05BC-4E02-9B00-AEAABA46ED2B Q37514746-69AC0535-B919-4CB2-B9C6-311FD32B598B Q37657753-0CAFC949-CD43-4AD1-A586-CC639BF0B7A4 Q37701814-04E757DB-6231-41C3-AC94-22314DCC7679 Q37789156-605A941A-21C7-411F-B1BA-D145174D1E36 Q37797498-E18DFA9D-866A-4A38-B4EE-C5B5160922CE Q37997003-C7B9EA87-6E5F-4D9C-9E8E-8E0AA3CC3000 Q38391987-459AE486-98CE-4C67-93A8-6762275BA6EB

P2860

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

http://www.wikidata.org/entity/Q36465265

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Identification of the function ...... progression of breast cancer.

@ast

Identification of the function ...... progression of breast cancer.

@en

type

label

Identification of the function ...... progression of breast cancer.

@ast

Identification of the function ...... progression of breast cancer.

@en

prefLabel

Identification of the function ...... progression of breast cancer.

@ast

Identification of the function ...... progression of breast cancer.

@en

P1433

Q36465265-64076870-8B64-4092-8BD2-2ADAE635CDF8

P1476

Q36465265-9E7954A5-8228-496C-9DDA-85C8E9A3001A

P2093

Q36465265-089E4F93-0B00-4253-A98E-08484383A8A7

Q36465265-1144E3C7-6CB8-4D66-9F9F-A6A34A401773

Q36465265-1AE2DB3D-CB39-4F56-B5E1-579905114603

Q36465265-2E574780-6082-4F6C-B18F-95A0E27E5A82

Q36465265-383F70FC-0B26-41C5-8DE6-D27A00A7CA74

Q36465265-7E74F72B-0510-4AC3-9B4E-0C0C8C3A6A83

Q36465265-A2D73EC5-6D14-43BA-B96E-918ED4A4AD38

Q36465265-A8B53EAE-E183-4B54-9876-9F23A2DBCA40

Q36465265-EB4A9DA2-B0F4-46C5-BB6A-07278AB8F662

Q36465265-F708A5C7-7769-4BA6-A0C7-F86C6CCE763D

P2860

Q36465265-075C7138-2198-487F-BB84-B79FC1214A00

Q36465265-27AC24EC-BD8E-4989-BF5E-8D81F747631E

Q36465265-2F8F6FA8-1E13-4274-B0B7-D875CB1E176E

Q36465265-438032FE-93C8-483D-87ED-04E94EE4923E

Q36465265-512A8D7C-9561-4482-A414-12EC587EBEDC

Q36465265-5B2393B0-05ED-4067-9C12-D6CF8E340F68

Q36465265-63E20969-C395-4C6D-8086-F74051C260F7

Q36465265-6A5CD1C4-7A7F-4DCE-B7CB-A707BA2F91EC

Q36465265-6B9C8561-5A1D-43C1-965D-F557561FC2D8

Q36465265-7BB588AE-C7F8-40E3-B715-D8560712282A

P2888

Q36465265-9A689C17-3F08-4FF3-A6A1-5F458B9D6D05

P304

Q36465265-D2D9BCA3-F2E4-4ECC-9840-670A23397E19

P31

Q36465265-025388C8-F7CC-485A-B785-C8513E697146

P356

Q36465265-41BE0172-464F-492A-937C-9359EC555D6C

P433

Q36465265-E2AC58B9-AAE8-43F9-ABCA-857BF1249CAD

P478

Q36465265-38918EEF-93C8-4717-9518-6214954EF40E

P577

Q36465265-787E6701-5F85-45C8-856C-6E0A0DF38E4D

P5875

Q36465265-9D2B4368-12E9-4F02-B05C-A1D2499D490F

P6179

Q36465265-08E4F9C9-8DE1-47F5-A267-EDD0F25D0CDD

P698

Q36465265-2587B73E-2B2C-4471-92B6-011C1AADBD60

P932

Q36465265-3CA8745A-3B2A-489D-9F2B-943E0AF85AC4

P356

P1433

Breast Cancer Research

P1476

Identification of the function ...... progression of breast cancer.

@en

P2093

Da-Qiang Li

http://www.w3.org/2001/XMLSchema#string

Gen-Hong Di

http://www.w3.org/2001/XMLSchema#string

Jin-Song Lu

http://www.w3.org/2001/XMLSchema#string

Jiong Wu

http://www.w3.org/2001/XMLSchema#string

Wei Jin

http://www.w3.org/2001/XMLSchema#string

Xin-Zhong Chang

http://www.w3.org/2001/XMLSchema#string

Yi-Feng Hou

http://www.w3.org/2001/XMLSchema#string

Zhen-Zhou Shen

http://www.w3.org/2001/XMLSchema#string

Zhi-Ming Shao

http://www.w3.org/2001/XMLSchema#string

Zhou-Luo Ou

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of a mammalian peroxiredoxin that contains one conserved cysteine

Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders

Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression

Overexpression of peroxiredoxin in human breast cancer

Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism

The transcription factor Ets-1 in breast cancer

Identification of a human cDNA clone for lysosomal type Ca2+-independent phospholipase A2 and properties of the expressed protein

Cancer statistics, 2007

Expression patterns of antioxidant proteins in brains of patients with sporadic Creutzfeldt-Jacob disease.

Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.

P2888

P304

R76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR1789

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5866665

http://www.w3.org/2001/XMLSchema#string

P6179

1053217794

http://www.w3.org/2001/XMLSchema#string

P698

17980029

http://www.w3.org/2001/XMLSchema#string

P932

2246172

http://www.w3.org/2001/XMLSchema#string